New Hope for Patients Suffering from Brain Tumors?
Mebendazole is being studied in treating glioblastoma multiforme. By: Tom Siegenthaler, DPh, RPh, FACA The antiparasitic drug mebendazole has shown improvement in 2 preclinical models of the brain cancer glioblastoma multiforme (GBM). Mebendazole has shown in laboratory and animal studies as a promising drug for GBM. Other studies have looked at combining